You have 9 free searches left this month | for more free features.

ASP015K

Showing 1 - 25 of 4,270

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Beijing (peficitinib)

Completed
  • Healthy Volunteers
  • Beijing, China
    Site CN86001
Dec 9, 2021

Healthy Subjects Trial in Kagoshima (peficitinib, Metformin)

Completed
  • Healthy Subjects
  • Kagoshima, Japan
    Site JP00001
Sep 19, 2019

Healthy Volunteers Trial in Tokyo (peficitinib)

Completed
  • Healthy Volunteers
  • Tokyo, Japan
    (unnamed)
Sep 13, 2019

Pharmacokinetics of ASP015K, Healthy Volunteer Trial in Kyushu (peficitinib, Placebo)

Completed
  • Pharmacokinetics of ASP015K
  • Healthy Volunteer
  • Kyushu, Japan
    (unnamed)
Sep 11, 2019

Arthritis, Rheumatoid Trial in Japan, Korea, Republic of, Taiwan (Peficitinib)

Completed
  • Arthritis, Rheumatoid
  • Nagoya, Aichi, Japan
  • +174 more
Sep 25, 2020

Rheumatoid Arthritis Trial in Japan (Peficitinib, Placebo, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Nagoya, Aichi, Japan
  • +145 more
Jul 16, 2020

Arthritis, Rheumatoid Trial in Japan (peficitinib, Placebo)

Completed
  • Arthritis, Rheumatoid
  • Chubu, Japan
  • +6 more
Jul 9, 2019

Rheumatoid Arthritis Trial in Anniston (peficitinib, methotrexate)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
    (unnamed)
Jun 6, 2019

Psoriasis Trial in United States (peficitinib, Placebo)

Completed
  • Psoriasis
  • Birmingham, Alabama
  • +10 more
Jun 6, 2019

Rheumatoid Arthritis Trial in Japan, Korea, Republic of, Taiwan (Peficitinib, Placebo, Etanercept)

Completed
  • Rheumatoid Arthritis
  • Nagoya, Aichi, Japan
  • +152 more
Mar 1, 2020

Patients With Impaired Renal Function Trial in Tokyo (ASP015K)

Completed
  • Patients With Impaired Renal Function
  • ASP015K
  • Tokyo, Japan
  • +1 more
Apr 5, 2019

Patients With Impaired Hepatic Function Trial in Fukuoka, Kanagawa, Tokyo (ASP015K)

Completed
  • Patients With Impaired Hepatic Function
  • ASP015K
  • Fukuoka, Japan
  • +5 more
Apr 5, 2019

Arthritis, Rheumatoid Trial in Worldwide (peficitinib)

Completed
  • Arthritis, Rheumatoid
  • Birmingham, Alabama
  • +50 more
May 20, 2019

Arthritis, Rheumatoid Trial in Worldwide (peficitinib, Placebo)

Completed
  • Arthritis, Rheumatoid
  • Birmingham, Alabama
  • +37 more
May 29, 2019

Arthritis, Rheumatoid Trial in Worldwide (peficitinib, Placebo, methotrexate)

Completed
  • Arthritis, Rheumatoid
  • Birmingham, Alabama
  • +48 more
May 29, 2019

Colitis, Ulcerative Trial in Worldwide (Placebo, JNJ-54781532 25 mg once daily, JNJ-54781532 75 mg once daily)

Completed
  • Colitis, Ulcerative
  • Placebo
  • +4 more
  • La Jolla, California
  • +101 more
Jan 3, 2019

NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)

Active, not recruiting
  • NonSegmental Vitiligo
  • Hoover, Alabama
  • +30 more
Nov 14, 2022

Myopia Trial in Worldwide (NVK-002 Concentration 1, NVK-002 Concentration 2, Placebo)

Active, not recruiting
  • Myopia
  • NVK-002 Concentration 1
  • +2 more
  • Tucson, Arizona
  • +25 more
Jan 3, 2023

Physical Inactivity Trial (Motor Skills Intervention)

Not yet recruiting
  • Physical Inactivity
  • Motor Skills Intervention
  • (no location specified)
Apr 18, 2022

HIV Trial in Montpellier (20 ml blood test)

Not yet recruiting
  • HIV Infections
  • 20 ml blood test
  • Montpellier, Herault, France
    La Colombiere Hospital
Feb 8, 2022

Epilepsy Trial in Worldwide (Lacosamide)

Completed
  • Epilepsy
  • Birmingham, Alabama
  • +68 more
Dec 17, 2021

Hypertrophic Cardiomyopathy Trial in Madrid ("Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3"

Recruiting
  • Hypertrophic Cardiomyopathy
  • "Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3" generator (Renal Denervation System)
  • Madrid, Spain
    Hospital Universitario 12 de Octubre
Nov 26, 2022

Evaluation in Clinical Practice of Urinary Disorders in Multiple

Not yet recruiting
  • Multiple Sclerosis
  • Urinary Bladder, Neurogenic
  • Initial management of the urinary disorder/s identified during the screening phase
  • Vittoria, Ragusa, Italy
    Multiple Sclerosis Center of ASP 7 Ragusa
Sep 29, 2021

Osteoarthritis Trial in India (Diclofenac Sodium Topical Gel, 1%, Voltaren Topical Gel, 1%, Vehicle Diclofenac Sodium Topical

Completed
  • Osteoarthritis
  • Diclofenac Sodium Topical Gel, 1%
  • +2 more
  • Secunderabad, Andhra Pradesh, India
  • +22 more
May 21, 2021